Nova Publishers
My Account Nova Publishers Shopping Cart
HomeBooksSeriesJournalsReference CollectionseBooksInformationSalesImprintsFor Authors
            
  Top » Catalog » Books » Most recent entries » Horizons in World Cardiovascular Research. Volume 2 Chapters » My Account  |  Cart Contents  |  Checkout   
Quick Find
  
Use keywords to find the product you are looking for.
Advanced Search
What's New? more
Sleep Deprivation: Global Prevalence, Dangers and Impacts on Cognitive Performance
$73.80
Shopping Cart more
0 items
Information
Shipping & Returns
Privacy Notice
Conditions of Use
Contact Us
Notifications more
NotificationsNotify me of updates to Beneficial Clinical Effects of Perhexiline in Cardiac Patients: Multiple Biochemical Mechanisms, pp. 1-27
Tell A Friend
 
Tell someone you know about this product.
Beneficial Clinical Effects of Perhexiline in Cardiac Patients: Multiple Biochemical Mechanisms, pp. 1-27 $100.00
Authors:  (Yuliy Y. Chirkov, Aaron L. Sverdlov, John D. Horowitz, Basil Hetzel Institute, The Queen Elizabeth Hospital/Dept. of Medicine, The University of Adelaide, Australia)
Abstract:
Perhexiline, 2-(2,2-dicyclohexylethyl)piperidine, was originally developed as a prophylactic anti-anginal drug in the late 1960s. It was initially a popular and effective treatment for angina, having the almost unique property compared to other agents available at that time, of not inducing reductions in blood pressure or heart rate. Despite the initial success, its use diminished markedly due to the occurrence during long-term therapy of poorly understood side effects (neurotoxicity and hepatotoxicity), which later were shown to be associated with high plasma concentrations of perhexiline, occurring in patients with relatively slow hepatic metabolism of the drug. However, therapeutic plasma monitoring and associated dose adjustments have led to perhexiline's reintroduction into clinical practice. Recent clinical data have proved its safety and
maintained efficacy. Perhexiline reduced anginal frequency in patients with refractory angina. In patients with chronic heart failure, perhexiline improved peak exercise oxygen consumption, left ventricular ejection fraction, symptoms, resting and peak stress
myocardial function. Perhexiline also appears to be effective in suppressing symptoms in patients with acute coronary syndromes or with advanced and inoperable aortic valvular stenosis. Herein we discuss perhexiline's pharmacology with particular emphasis on its
mechanism(s) of action. 


Available Options:
Version:
Special Focus Titles
01.Emerson’s Eastern Education
02.Terrorism in a Global Village: How Terrorism Affects Our Daily Lives
03.Listening to their Voices of Bravery and Heroism: Exploring the Aftermath of Officers’ Loss and Trauma in the Line of Duty
04.Diabetes Mellitus: A Medical History Journey
05.Geriatric Orthoptics and Non-Paretic Diplopia in Adults
06.Biologics in Rheumatology: New Developments, Clinical Uses and Health Implications
07.Empathy Rules: Depression, Schadenfreude and Freudenfreude Research on Depression Risk Factors and Treatment
08.Advances in Natural Products Discovery
09.The Cutoff Plan: How a Bold Engineering Plan Broke with U.S. Army Corps of Engineers Policy and Saved the Mississippi Valley
10.The Law of Air, Road and Sea Transportation
11.The George W. Bush Presidency. Volume I: The Constitution, Politics, and Policymaking
12.Conflict and Communication: A Changing Asia in a Globalizing World – Language and Cultural Perspectives

Nova Science Publishers
© Copyright 2004 - 2016

Beneficial Clinical Effects of Perhexiline in Cardiac Patients: Multiple Biochemical Mechanisms, pp. 1-27